Indoles
US7799923B2 · kind B2 · utility
3Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 29, 2007 |
| Grant date | Sep 21, 2010 |
| Priority date | — |
| Expiry date | Nov 10, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is concerned with novel indol-2-yl-carbonyl-piperidin-benzoimidazolon and indol-2-yl-carbonyl-piperidin-benzoxazolon derivatives as V1a receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use for the treatment of anxiety and depressive disorders and other diseases. In particular, the present invention concerns compounds of formula (I)wherein R1 to R11, X and Y are as defined in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.